Abstract

Experimental autoimmune prostatitis (EAP) is a well-established model induced by an autoimmune response to prostate antigen. The symptomatic, pathological, and immunological characteristics of EAP animals are highly consistent with human chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), which makes EAP an ideal model for this disease. Here, we investigate the influence of EAP on male rat sexual function and the efficacy of anti-inflammatory therapy with celecoxib. EAP rat models were established using male Wistar rats. Rats were randomly assigned to a normal control group, an EAP model group, or an EAP model with celecoxib treatment group (celecoxib group). Behavioral changes, sexual behavioral changes, and erectile function were estimated using an open-field test, a sucrose consumption test, mating experiments, and by intracavernous pressure/mean arterial pressure ratio (ICP/MAP). Histological changes in the prostate were observed by HE staining, and the serum inflammatory factors IL-1β and TNF-α levels were measured by enzyme-linked immunosorbent assay. In addition, serotonin (5-hydroxytryptamine, 5-HT), 5-HT1A receptor, 5-HT2C receptor, and serotonin transporter (SERT) expression levels in the hippocampus and spinal cord (T13–L1, L5–S2) were examined by immunohistochemistry and western blot analysis. Results showed that EAP rats exhibited characteristics of depression, decreased sexual drive, premature ejaculation, and increased threshold of penile erection. Moreover, all these changes were effectively alleviated by celecoxib. Significant increases in prostatic interstitial infiltration by inflammatory cells and in serum IL-1β and TNF-α levels were observed in EAP rats, and these were partially reduced by celecoxib. Additionally, the expression pattern of serotonin system regulators in the hippocampus and spinal cord were altered in EAP model rats, including a decrease in 5-HT levels and an increase in 5-HT1A receptor levels. In conclusion, autoimmune prostatitis impaired rat sexual function, and this was effectively prevented by anti-inflammatory therapy with celecoxib. Moreover, a serotonin system disorder in the central nervous system was likely mediated via inflammation in EAP rats.

Highlights

  • Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is an inflammatory disease affecting around 8.2% of the male population throughout the world [1]

  • We report that autoimmune prostatitis caused depression-like behavior and impairment of sexual function in the Experimental autoimmune prostatitis (EAP) rat model

  • All rats exhibited normal active behaviors, and no significant difference in horizontal movement score, vertical movement score, or sucrose water preference was observed between the three groups (P > 0.05)

Read more

Summary

Introduction

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is an inflammatory disease affecting around 8.2% of the male population throughout the world [1]. Common complications of CP/CPPS patients include sexual dysfunction and anxietyrelated disorders [2, 3], as confirmed in our previous study [4]. In our single-center study, the incidences of premature ejaculation (PE) and erectile dysfunction (ED) in CP/CPPS patients were about 45.3 and 47.4%, respectively [4], while the prevalence of PE was reported up to 64.1 and 36.9% in prostatitis-like symptom and chronic prostatitis group from another epidemiological investigation [5]. Anxiety-related disorders comprised the highest risk factors for sexual dysfunction in CP/CPPS based on our data [4]. The relationship among CP/CPPS, anxiety-related disorders, and sexual dysfunction was difficult to clarify because of the various confounding factors

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call